Skip Navigation


Carcinogenesis Advance Access originally published online on November 26, 2008
Carcinogenesis 2009 30(2):282-285; doi:10.1093/carcin/bgn264
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/2/282    most recent
bgn264v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Arab, K.
Right arrow Articles by Bartsch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arab, K.
Right arrow Articles by Bartsch, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Typical signature of DNA damage in white blood cells: a pilot study on etheno adducts in Danish mother–newborn child pairs

K. Arab1,2,*, M. Pedersen3, J. Nair2, M. Meerang2, L. E. Knudsen3 and H. Bartsch2

1 Division of Epigenomics
2 Division of Toxicology and Cancer Risk Factors (C010), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
3 Department of Environmental Health, Institute of Public Health, University of Copenhagen, 1014 K Copenhagen, Denmark

* To whom correspondence should be addressed. Tel: +49 6221 423337; Fax: +49 6221 423359; Email: a.khelifa{at}dkfz.de

The impact of DNA damage commonly thought to be involved in chronic degenerative disease causation is particularly detrimental during fetal development. Within a multicenter study, we analyzed 77 white blood cell (WBC) samples from mother–newborn child pairs to see if imprinting of DNA damage in mother and newborn shows a similar pattern. Two adducts 1,N6-ethenodeoxyadenosine ({varepsilon}dA) and 3,N4-ethenodeoxycytidine ({varepsilon}dC) were measured by our ultrasensitive immunoaffinity 32P-post-labeling method. These miscoding etheno-DNA adducts are generated by the reaction of lipid peroxidation (LPO) end products such as 4-hydroxy-2-nonenal with DNA bases. Mean {varepsilon}dA and {varepsilon}dC levels when expressed per 109 parent nucleotides in WBC-DNA from cord blood were 138 and 354, respectively; in maternal WBC-DNA, the respective values were 317 and 916. Thus, the DNA-etheno adduct levels were reliably detectable and about two times lower in child cord blood, the difference being significant at P < 0.0004. Analysis of {varepsilon}dA and {varepsilon}dC levels in cord versus maternal blood WBC showed strong positive correlations (R2 {approx} 0.9, P < 0.00001). In conclusion, LPO-induced DNA damage arising from endogenous reactive aldehydes in WBC of both mother and newborn can be reliably assessed by {varepsilon}dA and {varepsilon}dC as biomarkers. The high correlation of etheno adduct levels in mother and child WBC suggests that a typical signature of DNA damage is induced similarly in fetus and mother. Prospective cohort studies have to reveal whether these two WBC-DNA adducts could serve as risk indicator for developing hematopoietic cancers and other disorders later in life.

Abbreviations: {varepsilon}dA, 1,N6-ethenodeoxyadenosine; {varepsilon}dC, 3,N4-ethenodeoxycytidine; LPO, lipid peroxidation; M1dG, 3-(2-deoxy-D-erythro-pentofuranosyl)pyrimido[1,2-]purin-10(3H)-one; WBC, white blood cell

Received September 19, 2008; revised November 13, 2008; accepted November 18, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.